Subscribe for great stories in your community!
FinPay Holdings, the King of Prussia fintech, has closed its $15 million capital raise and is planning to use the funds to double revenue once…
Plymouth Meeting-based Braeburn has found its way onto a new Forbes list ranking the 500 best startup employers in America, writes Ryan Mulligan for…
Endo International, with U.S. headquarters in Malvern, has decided on a unique tagline for its latest marketing program for cellulite treatment Qwo: “Butt First…
Plymouth Meeting-based Inovio is adopting a new strategy in the hopes of gaining regulatory approval for its COVID-19 vaccine candidate, INO-4800, writes…
The annual rankings from Forbes and Statista, the world-leading statistics portal and industry ranking provider, are based on an independent survey of approximately 60…
Hatfield-based Code Biotherapeutics has entered into a collaboration and option deal with Takeda with a potential value of $2 billion, writes John George for…
“Our collective hope shines a light on the progress made and challenges ahead,” CSL Behring Limited CEO and Managing Director Paul Perreault said in a…
The new analytical testing services laboratory opened by the Center for Breakthrough Medicines at the Discovery Labs complex in King of Prussia aims to address…
The CEO of a Radnor-based pharmaceutical company, Dr. Scott Braunstein, M.D., has made a top 25 list of Biotech CEOs for 2022, compiled…
At the celebratory event, presented by global biotherapies leader CSL Behring, Uplifting Athletes awarded $180,000 in research grants to nine promising young investigative rare…
Abington’s Katalin Kariko is one of the Heroes of the Year, a group of scientists who introduced an innovative and highly effective mRNA-based…
University of Pennsylvania Professor James Wilson recently signed a five-year renewable deal on behalf of his gene therapy lab to license its manufacturing process…
Actress Jennifer Aniston talks about her struggles with insomnia in a commercial for Swiss pharmaceutical company Idorsia, which has U.S. operations on the Main…
The Center for Breakthrough Medicines, which is based within MLP Ventures’ Discovery Labs innovation hub campus in King of Prussia, has secured an equity investment…
Dr. Katalin Karikó, an Abington resident and senior vice president of BioNTech, has been researching the mRNA vaccine for decades, but it was only after…
The revolutionary mRNA research by Abington biochemist Katalin Karikó and her collaborator immunologist Drew Weissman could be the key to solving scores of health problems…
Before we send you to this site, please subscribe to our daily newsletter.